Compounds > 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and technetium

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with technetium in 1 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Studies
(technetium)		Trials
(technetium)		Recent Studies (post-2010) (technetium)
254820,2024431,434

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuttani, K; Datta, A; Mishra, AK; Panwar, P1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and technetium

ArticleYear
Synthesis of 99mTc-DOTMP and its preclinical evaluation as a multidentate imaging agent for skeletal metastases.
    Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:1

    Topics: Animals; Bone Neoplasms; Chelating Agents; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rats; Technetium; Time Factors; Tissue Distribution

2009